NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tarn Biosciences

Tarn Biosciences

Private
East Lansing, MichiganHealthcare & Life Scienceshttps://tarnbio.com/

Last Round

Grant

Sep 1, 2023

Total Funding Raised

$1.25M

Company Overview

Tarn Biosciences is a biotechnology company that develops novel therapies for tuberculosis and non-tuberculous mycobacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

drug discoverybiotechtuberculosis treatmentsmall molecule inhibitorsNTM infectionsmycobacterial infectionsMmpL3 inhibitorspreclinical researchdrug developmentantibiotic resistancetherapeuticspharma R&DTBdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tarn Biosciences Comparables

Compare Tarn Biosciences with similar companies based on industry and business-model similarity.

Tarn Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hsiri Therapeutics
81%
Sequella, Inc.
78%
Spero Therapeutics, Inc.
70%

Tarn Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2023
GrantJul 6, 2023
GrantAug 19, 2022

Tarn Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2023

    $587K grant received from the National Institutes of Health.

Tarn Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tarn Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tarn Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersEast Lansing, Michigan
Year Founded2018
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.